Somavert Alternatives Compared
| Somavert | Sandostatin LAR Depot | Octreotide |
|
|---|
| Somavert (pegvisomant) | Sandostatin LAR Depot (octreotide) | Octreotide |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Acromegaly. Somavert may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Carcinoid Tumor, Acromegaly, Vasoactive Intestinal Peptide Tumor. Sandostatin LAR Depot may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Carcinoid Tumor, Diarrhea, Acromegaly, Vasoactive Intestinal Peptide Tumor, Diabetes - Type 1, Dumping Syndrome, Gastrinoma, Glucagonoma, Insulinoma, Pituitary Adenoma, Postural... View more |
Related suggestions Popular comparisons
|
|||||||||||||||||||||||
| More about Somavert (pegvisomant) | More about Sandostatin LAR Depot (octreotide) | More about Octreotide | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Somavert has an average rating of 4.7 out of 10 from a total of 4 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 67% reported a negative effect. |
Sandostatin LAR Depot has an average rating of 8.3 out of 10 from a total of 6 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Octreotide has an average rating of 7.6 out of 10 from a total of 17 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: Somavert side effects in more detail. |
See also: Sandostatin LAR Depot side effects in more detail. |
See also: octreotide side effects in more detail. |
||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic approved |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Somavert prices |
View all Sandostatin LAR Depot prices |
View all octreotide prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other octreotide brands include: Bynfezia Pen, Mycapssa, Sandostatin | Bynfezia Pen, Mycapssa, Sandostatin, Sandostatin LAR Depot | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
144 hours |
1.5 hours |
1.5 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 74 drugs are known to interact with Somavert:
|
A total of 156 drugs are known to interact with Sandostatin LAR Depot:
|
A total of 156 drugs are known to interact with octreotide:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
March 25, 2003 |
N/A |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.